SHENZHEN, China, August 21, 2013 /PRNewswire/ -- ANV Security Group (OTCBB: ANVS) announces today that it has signed Peking University Shenzhen School of Medicine as a new customer. Peking University Shenzhen School of Medicine operates under Peking University Health Science Center (PUHSC) and is China's leading medical teaching institute.
Doctors and medical students will now be able to utilize ANV's Global Intelligent Eye (GIE) platform to remotely observe patients in real-time and communicate with those patients or nursing staff and provide instructions if required.
"As a large institutional customer, the Shenzhen School of Medicine represents a significant opportunity for the GIE platform to prove itself in a more demanding customer environment and validates the stability and reliability of our technology and hardware," said ANV Security Group Chairman, Wilson Wang.
The Company's Global Intelligent Eye (GIE) service allows subscribers, both large and small, to easily monitor their home, office, or facilities from remote locations on any device that is connected to the internet. GIE uses internet protocol and proprietary, true plug-and-play, hardware technology to provide real-time live video and sound feeds to subscriber's internet enabled devices- handhelds, laptops, smartphones and computers.
For just pennies a day per installed unit, ANV's GIE platform is accessible to all internet users in China. Subscribers that sign long-term contracts receive their hardware units for free. With added hardware, GIE is also able to monitor smoke, fire, carbon monoxide, doors and windows, and more. The Company's patented alerting technology can send notifications and alerts using email, text message, or even a phone call.
GIE was officially launched in China one year ago and remains the first consumer-focused video monitoring technology to be widely available across the country.
The Company says that GIE will soon become available in select emerging markets and North America. Inquiries are welcomed.
About Peking University Health Science Center
PUHSC offers a full range of courses for eight specialties including basic medical sciences, clinical medicine, preventive medicine, stomatology, pharmacy, nursing, medical laboratory diagnosis and biomedical English. It has 57 accredited doctoral programs and 66 masters programs. In addition to offering undergraduate and graduate programs, PUHSC also plays an active role in continuing education. PUHSC hosts six postdoctoral programs. PUHSC has an enrollment of 10,112 students, including 927 doctoral students, 1,036 masters program students, 3,196 undergraduates, 696 junior college students, 3,994 adult learning program students, and 388 international students.
PUHSC has developed 20 disciplines that have gained national recognition. Besides, it has one national key laboratory, 10 ministry-level key laboratories, 23 joint research centers, and 20 research institutes at university level. PUHSC has 11 schools, one institute and one division: School of Basic Medical Sciences, School of Pharmaceutical Sciences, School of Public Health, School of Nursing, School of Stomatology, the First School of Clinical Medicine (Beida Hospital), the Second School of Clinical Medicine (the People's Hospital), the Third School of Clinical Medicine (the Third Hospital), Institute of Mental Health (the Sixth Hospital), the School of Oncology (Beijing Tumor Hospital), Peking University Shenzhen School of Medicine, Peking University School of Telemedical Education, and the Division of Humanity and Fundamental Sciences. In addition, 15 hospitals in Beijing serve as teaching hospitals.
About ANV Group
ANV Security Group, Inc. (ANVS) was formally established in 2006 and became a public company in 2009 through a reverse merger transaction. Registered as a Nevada corporation, the Company currently trades on the OTCBB exchange under the stock symbol "ANVS". In 2010, the Company moved its headquarters from Vancouver, Canada to Shenzhen, a Special Economic Zone, in Southern China, where it continues to focus on research and development of its technology platforms and service solutions.
As a research and development company, ANVS developed and patented the world's first large-scale cloud-based intelligent video and security alarm technology, having been issued its patent in October 2009 (US2009/0265747A1). The patent and technology enables multi-platform security monitoring and alerts that are scalable for multinational enterprises and even home usage. Any triggered alarm instantly alerts users via SMS, e-mail, telephone, mobile phone, or a combination of any, worldwide, and captures the event images in video surveillance servers.
In 2011, ANV Security Group launched Global Intelligent Eye (GIE) to be a cost effective digital security monitoring solutions service provider for customers large and small. Tested in Canada and launched in China, GIE is focused on customer support and backend service for its multi-platform security monitoring and alerts in real-time through the internet or 3G networks. Customers are able to use a desktop computer, laptop, smart phone, or any other internet enabled device to visually monitor their locations where ANV devices have been installed.
Forward Looking Statements
This press release and the statements of representatives of ANV Security Group, Inc. (the "Company") related thereto contain, or may contain, among other things, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact included herein are "forward-looking statements," including any other statements of non-historical information. These forward-looking statements are subject to significant known and unknown risks and uncertainties and are often identified by the use of forward-looking terminology such as "projects," "may," "could," "would," "should," "believes," "expects," "anticipates," "estimates," "intends," "plans," "ultimately" or similar expressions. All forward-looking statements involve material assumptions, risks and uncertainties, and the expectations contained in such statements may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including factors and risks discussed in the periodic reports that the Company files with the Securities and Exchange Commission (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. The Company undertakes no duty to update these forward-looking statements except as required by law.
Additional information is available at www.anvsecuritygroup.com.
Contact:
Investor Relations
Humayun Shakeel
Office: +86-755-8665-6426 Ext 8024
Mb: +86-180-0258-4257, +86-138-1157-7003
IR@anvsecuritygroup.com
![[Poster] Analytical Performance Experimentation assessment of the miLab™ MAL Malaria system for the detection of Plasmodium falciparum in clinical samples in Lagos, Nigeria](https://mma.prnasia.com/media2/2395917/Poster__Analytical_Performance_Experimentation_assessment_of_the_miLab__MAL_Malaria_system_for_the_d.jpg?p=medium600)
